Masimo (NASDAQ:MASI) Updates FY 2025 Earnings Guidance

Masimo (NASDAQ:MASI) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 4.900-5.100 for the period, compared to the consensus earnings per share estimate of 4.670. The company issued revenue guidance of -. Masimo also updated its FY 2024 guidance to 4.100-4.100 EPS.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Wells Fargo & Company lifted their price target on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research note on Wednesday, November 6th. BTIG Research raised their price target on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Stifel Nicolaus reissued a “buy” rating and issued a $190.00 price objective (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Finally, Raymond James raised their target price on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $179.67.

Masimo Price Performance

NASDAQ:MASI opened at $174.54 on Thursday. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The firm has a fifty day simple moving average of $168.86 and a 200 day simple moving average of $139.54. Masimo has a 1-year low of $101.61 and a 1-year high of $180.97. The stock has a market capitalization of $9.34 billion, a PE ratio of 120.37 and a beta of 1.01.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company had revenue of $504.60 million for the quarter, compared to analyst estimates of $502.87 million. During the same period in the previous year, the business earned $0.63 EPS. Masimo’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, research analysts expect that Masimo will post 4.03 EPS for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.